SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. Financials Shanghai United Imaging Healthcare Co., Ltd.
Equities
688271
CNE100005PN5
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 129.3 CNY | -2.09% |
|
-1.68% | -5.63% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 145,859 | 112,918 | 105,954 | - | - |
| Enterprise Value (EV) 1 | 135,816 | 105,394 | 96,656 | 95,376 | 93,317 |
| P/E ratio | 80.8 x | 57.1 x | 44.8 x | 36.7 x | 29.6 x |
| Yield | 0.11% | 0.18% | 0.27% | 0.3% | 0.41% |
| Capitalization / Revenue | 15.8 x | 9.9 x | 7.69 x | 6.13 x | 5.09 x |
| EV / Revenue | 14.7 x | 9.24 x | 7.01 x | 5.52 x | 4.49 x |
| EV / EBITDA | 61.7 x | 42.7 x | 37.2 x | 29.1 x | 24.1 x |
| EV / FCF | -2,391 x | -112 x | 50.8 x | 54.4 x | 35.4 x |
| FCF Yield | -0.04% | -0.89% | 1.97% | 1.84% | 2.82% |
| Price to Book | 8.34 x | 5.99 x | 5.08 x | 4.51 x | 3.92 x |
| Nbr of stocks (in thousands) | 824,158 | 824,158 | 819,441 | - | - |
| Reference price 2 | 177.0 | 137.0 | 129.3 | 129.3 | 129.3 |
| Announcement Date | 23-02-27 | 24-02-27 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 9,238 | 11,411 | 13,782 | 17,276 | 20,805 |
| EBITDA 1 | - | 2,201 | 2,467 | 2,596 | 3,282 | 3,876 |
| EBIT 1 | - | 1,928 | 2,142 | 2,636 | 3,294 | 3,991 |
| Operating Margin | - | 20.87% | 18.77% | 19.13% | 19.06% | 19.18% |
| Earnings before Tax (EBT) 1 | - | 1,920 | 2,142 | 2,679 | 3,318 | 4,088 |
| Net income 1 | 1,417 | 1,656 | 1,974 | 2,372 | 2,896 | 3,588 |
| Net margin | - | 17.93% | 17.3% | 17.21% | 16.76% | 17.25% |
| EPS 2 | 1.960 | 2.190 | 2.400 | 2.883 | 3.520 | 4.370 |
| Free Cash Flow 1 | - | -56.8 | -943.2 | 1,901 | 1,754 | 2,634 |
| FCF margin | - | -0.61% | -8.27% | 13.8% | 10.15% | 12.66% |
| FCF Conversion (EBITDA) | - | - | - | 73.24% | 53.42% | 67.97% |
| FCF Conversion (Net income) | - | - | - | 80.16% | 60.55% | 73.43% |
| Dividend per Share 2 | - | 0.2010 | 0.2500 | 0.3478 | 0.3840 | 0.5325 |
| Announcement Date | 22-07-28 | 23-02-27 | 24-02-27 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,687 | 3,380 | 2,213 | 3,058 | 5,271 | 2,161 | 3,978 | 2,350 | 3,548 | 2,691 | 4,977 | 3,075 | 4,294 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT | -65.84 | 908.4 | 363.2 | 348.5 | 577.8 | 117.4 | - | 400.4 | - | - | - | - | - |
| Operating Margin | -3.9% | 26.88% | 16.41% | 11.39% | 10.96% | 5.43% | - | 17.04% | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | 687.7 | 1,047 | 119.2 | - | 399.7 | - | - | - | - | - |
| Net income | - | - | - | 608.1 | 937.8 | 126.5 | - | - | - | - | - | - | - |
| Net margin | - | - | - | 19.88% | 17.79% | 5.85% | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - | - | 0.4400 | 0.8500 | 0.4500 | 1.140 | 0.6600 | 0.9900 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 22-10-28 | 23-02-27 | 23-04-27 | 23-08-18 | 23-08-18 | 23-10-27 | 24-02-27 | 24-04-27 | - | - | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | 10,043 | 7,524 | 9,298 | 10,578 | 12,636 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -56.8 | -943 | 1,901 | 1,754 | 2,635 |
| ROE (net income / shareholders' equity) | - | 17.5% | 10.8% | 11.5% | 12.5% | 13.8% |
| ROA (Net income/ Total Assets) | - | 9.58% | 7.97% | 9.25% | 9.4% | 11.5% |
| Assets 1 | - | 17,283 | 24,770 | 25,643 | 30,808 | 31,199 |
| Book Value Per Share 2 | - | 21.20 | 22.90 | 25.50 | 28.70 | 32.90 |
| Cash Flow per Share 2 | - | 0.8300 | 0.1600 | 2.200 | 3.490 | 3.290 |
| Capex 1 | - | 740 | 1,076 | 868 | 808 | 628 |
| Capex / Sales | - | 8.01% | 9.43% | 6.3% | 4.68% | 3.02% |
| Announcement Date | 22-07-28 | 23-02-27 | 24-02-27 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
129.3
CNY
Average target price
155
CNY
Spread / Average Target
+19.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.63% | 14.67B | |
| -37.92% | 2.85B | |
| -11.25% | 2.51B | |
| -14.46% | 1.42B | |
| -.--% | 1.12B | |
| +53.85% | 566M | |
| +88.72% | 507M | |
| +24.09% | 269M | |
| -4.69% | 221M | |
| +6.67% | 195M |
- Stock Market
- Equities
- 688271 Stock
- Financials Shanghai United Imaging Healthcare Co., Ltd.
